Parsons MW - Search Results

1

Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.

Picanço MR, Christensen S, Campbell BC, Churilov L, Parsons MW, Desmond PM, Barber PA, Levi CR, Bladin CF, Donnan GA, Davis SM; EPITHET Investigators. Picanço MR, et al. Among authors: parsons mw. Int J Stroke. 2014 Apr;9(3):266-9. doi: 10.1111/ijs.12209. Epub 2013 Nov 21. Int J Stroke. 2014. PMID: 24256139 Clinical Trial.

2

Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke.

Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM. Parsons MW, et al. Ann Neurol. 2002 Jan;51(1):28-37. doi: 10.1002/ana.10067. Ann Neurol. 2002. PMID: 11782981 Clinical Trial.

3

Relationship between severity of MR perfusion deficit and DWI lesion evolution.

Parsons MW, Barber PA, Davis SM. Parsons MW, et al. Neurology. 2002 Jun 11;58(11):1707; author reply 1707. doi: 10.1212/wnl.58.11.1707. Neurology. 2002. PMID: 12058118 No abstract available.

4

Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study.

Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM. Parsons MW, et al. Ann Neurol. 2002 Jul;52(1):20-8. doi: 10.1002/ana.10241. Ann Neurol. 2002. PMID: 12112043

5

Examining the lacunar hypothesis with diffusion and perfusion magnetic resonance imaging.

Gerraty RP, Parsons MW, Barber PA, Darby DG, Desmond PM, Tress BM, Davis SM. Gerraty RP, et al. Among authors: parsons mw. Stroke. 2002 Aug;33(8):2019-24. doi: 10.1161/01.str.0000020841.74704.5b. Stroke. 2002. PMID: 12154256 Clinical Trial.

6

The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome.

Baird TA, Parsons MW, Barber PA, Butcher KS, Desmond PM, Tress BM, Colman PG, Jerums G, Chambers BR, Davis SM. Baird TA, et al. Among authors: parsons mw. J Clin Neurosci. 2002 Nov;9(6):618-26. doi: 10.1054/jocn.2002.1081. J Clin Neurosci. 2002. PMID: 12604269 Review.

7

Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital.

Szoeke CE, Parsons MW, Butcher KS, Baird TA, Mitchell PJ, Fox SE, Davis SM. Szoeke CE, et al. Among authors: parsons mw. Med J Aust. 2003 Apr 7;178(7):324-8. doi: 10.5694/j.1326-5377.2003.tb05223.x. Med J Aust. 2003. PMID: 12670274

8

Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.

Baird TA, Parsons MW, Phan T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM. Baird TA, et al. Among authors: parsons mw. Stroke. 2003 Sep;34(9):2208-14. doi: 10.1161/01.STR.0000085087.41330.FF. Epub 2003 Jul 31. Stroke. 2003. PMID: 12893952 Clinical Trial.

9

PWI/DWI mismatch: better definition required.

Butcher KS, Parsons MW, Davis S, Donnan G. Butcher KS, et al. Among authors: parsons mw. Stroke. 2003 Nov;34(11):e215-6; author reply e215-6. doi: 10.1161/01.STR.0000099066.23627.24. Epub 2003 Oct 23. Stroke. 2003. PMID: 14576368 No abstract available.

10

The use of PWI and DWI measures in the design of "proof-of-concept" stroke trials.

Barber PA, Parsons MW, Desmond PM, Bennett DA, Donnan GA, Tress BM, Davis SM. Barber PA, et al. Among authors: parsons mw. J Neuroimaging. 2004 Apr;14(2):123-32. J Neuroimaging. 2004. PMID: 15095557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

315 results

Search Page